Li PK - Search Results

1

Design, synthesis, and studies of small molecule STAT3 inhibitors.

Bhasin D, Cisek K, Pandharkar T, Regan N, Li C, Pandit B, Lin J, Li PK. Bhasin D, et al. Among authors: li c, li pk. Bioorg Med Chem Lett. 2008 Jan 1;18(1):391-5. doi: 10.1016/j.bmcl.2007.10.031. Epub 2007 Oct 17. Bioorg Med Chem Lett. 2008. PMID: 18006313

2

Structure-activity relationships studies of the anti-angiogenic activities of linomide.

Shi J, Xiao Z, Ihnat MA, Kamat C, Pandit B, Hu Z, Li PK. Shi J, et al. Among authors: li pk. Bioorg Med Chem Lett. 2003 Mar 24;13(6):1187-9. doi: 10.1016/s0960-894x(03)00047-7. Bioorg Med Chem Lett. 2003. PMID: 12643940

3

Conformationally restricted analogs of Combretastatin A-4 derived from SU5416.

Li PK, Xiao Z, Hu Z, Pandit B, Sun Y, Sackett DL, Werbovetz K, Lewis A, Johnsamuel J. Li PK, et al. Bioorg Med Chem Lett. 2005 Dec 15;15(24):5382-5. doi: 10.1016/j.bmcl.2005.09.001. Epub 2005 Oct 6. Bioorg Med Chem Lett. 2005. PMID: 16213720

4

A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.

Li PK, Pandit B, Sackett DL, Hu Z, Zink J, Zhi J, Freeman D, Robey RW, Werbovetz K, Lewis A, Li C. Li PK, et al. Among authors: li c. Mol Cancer Ther. 2006 Feb;5(2):450-6. doi: 10.1158/1535-7163.MCT-05-0254. Mol Cancer Ther. 2006. PMID: 16505120

5

Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416.

Pandit B, Sun Y, Chen P, Sackett DL, Hu Z, Rich W, Li C, Lewis A, Schaefer K, Li PK. Pandit B, et al. Among authors: li c, li pk. Bioorg Med Chem. 2006 Oct 1;14(19):6492-501. doi: 10.1016/j.bmc.2006.06.017. Epub 2006 Jul 24. Bioorg Med Chem. 2006. PMID: 16860559

6

Evaluation of the cytotoxicity of some mono-mannich bases and their corresponding azine derivatives against androgen-independent prostate cancer cells.

Gul HI, Das U, Pandit B, Li PK. Gul HI, et al. Among authors: li pk. Arzneimittelforschung. 2006;56(12):850-4. doi: 10.1055/s-0031-1296797. Arzneimittelforschung. 2006. PMID: 17260673

7

Synthesis of 4'-hydroxy-3'-piperidinomethylchalcone derivatives and their cytotoxicity against PC-3 cell lines.

Gul HI, Yerdelen KO, Gul M, Das U, Pandit B, Li PK, Secen H, Sahin F. Gul HI, et al. Among authors: li pk. Arch Pharm (Weinheim). 2007 Apr;340(4):195-201. doi: 10.1002/ardp.200600072. Arch Pharm (Weinheim). 2007. PMID: 17351963

8

Inhibitors of NF-kappaB derived from thalidomide.

de-Blanco EJ, Pandit B, Hu Z, Shi J, Lewis A, Li PK. de-Blanco EJ, et al. Among authors: li pk. Bioorg Med Chem Lett. 2007 Nov 1;17(21):6031-5. doi: 10.1016/j.bmcl.2007.01.088. Epub 2007 Feb 2. Bioorg Med Chem Lett. 2007. PMID: 17845850

9

Synthesis and cytotoxicity of novel 3-aryl-1-(3'-dibenzylaminomethyl-4'-hydroxyphenyl)-propenones and related compounds.

Gul HI, Yerdelen KO, Das U, Gul M, Pandit B, Li PK, Dimmock JR. Gul HI, et al. Among authors: li pk. Chem Pharm Bull (Tokyo). 2008 Dec;56(12):1675-81. doi: 10.1248/cpb.56.1675. Chem Pharm Bull (Tokyo). 2008. PMID: 19043238 Free article.

10

Curcumin is a potent DNA hypomethylation agent.

Liu Z, Xie Z, Jones W, Pavlovicz RE, Liu S, Yu J, Li PK, Lin J, Fuchs JR, Marcucci G, Li C, Chan KK. Liu Z, et al. Among authors: li c, li pk. Bioorg Med Chem Lett. 2009 Feb 1;19(3):706-9. doi: 10.1016/j.bmcl.2008.12.041. Epub 2008 Dec 14. Bioorg Med Chem Lett. 2009. PMID: 19112019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

795 results

Search Page

Filters